Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people each year and caused an | Genetics And Genomics ...

There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer ...

With determined leadership and smart use of current and future innovations, we can sustain momentum and accelerate progress ...

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

A team of scientists has identified an enzyme called PurF as a new drug target for tuberculosis, offering a fresh line of ...

(Reuters) - The World Health Organization on Tuesday reported that extensively drug-resistant tuberculosis (XDR-TB), a lethal strain of the contagious lung disease, has spread to 55 countries and ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

LONDON — Drug-resistant tuberculosis is spreading even faster than experts had feared, the World Health Organization warned Tuesday. The rate of TB patients infected with the drug-resistant strain ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Despite newer TB drugs, delayed diagnosis, atypical symptoms and drug resistance continue to complicate treatment ...